Synopsis
In vivo cardiac DTI using spin-echoes has been demonstrated on MR
systems equipped with powerful gradients. In this study we investigate the dependency
of helix and transverse angle error on maximum gradient amplitude for second
order motion compensated diffusion encoding of the in-vivo heart.
Root-mean-square errors for helix and transverse angles were 15.0±3.7°,
11.0±1.8°, 10.3±2.4°, and 11.7±3.8°, 9.0±2.0°, 8.1±2.2° for gradient strengths
of 30mT/m, 40mT/m and 60mT/m when compared to data obtained at 74.5 mT/m
gradient strength. From the data it is concluded that second order motion
compensated diffusion encoding allows for in vivo cardiac DTI even on MR
systems with standard gradient amplitudes of 40 mT/m.Introduction
In vivo
cardiac DTI (cDTI) using Stimulated Echo Acquisition Mode (STEAM) imaging has gained significant
attention
1-3. To address the sensitivity to motion and the limited
signal-to-noise ratio of cDTI using STEAM, spin-echo based approaches have been
pursued
4-6. Recently, second-order motion compensated diffusion
gradient waveforms have been proposed for spin-echo cDTI
7-9 and the
increase in SNR efficiency relative to STEAM has been demonstrated
10.
In addition, the single-shot method facilitates imaging during free-breathing
enhancing applicability in a clinical setting. So far, however, second-order motion-compensated
spin echo cDTI has only been demonstrated on MR scanners with high performance gradient
systems.
It
is the objective of the present work to investigate minimum gradient
performance requirements for second-order motion-compensated spin echo cDTI using in-vivo
data.
Methods
Second-order motion-compensated
spin echo cDTI (Figure1)
was implemented on a 1.5T Philips Achieva system (Philips Healthcare, Best, The
Netherlands) equipped with a 5-channel cardiac receiver array and a gradient
system delivering up to 80mT/m @ 100mT/m/ms. Data was acquired with ECG
triggering and during navigator gated (7 mm gating window) free breathing. The
maximum gradient strength (G
max) per physical axis was limited to
30mT/m, 40mT/m, 60mT/m and 74.5mT/m, the latter being the maximum applicable gradient
strength due to peripheral nerve stimulation limits. Diffusion encoding was
performed in three orthogonal directions at a b-value of 100s/mm
2 to
suppress perfusion effects
11 and along nine directions at b=450 s/mm
2
optimized to allow for an effective
G
max of 42.4mT/m, 56.6mT/m, 84.9mT/m and
105.4mT/m by utilizing the three physical gradient axes simultaneously. Corresponding
TEs were 96ms, 85ms, 73ms and 66ms. Imaging parameters were: resolution
2.6×2.6mm2, slice thickness 7mm, reduced FOV
12 230×104mm2,
signal averages 12, TR=3 R-R. Three short-axis slices at basal, mid-ventricular
and apical level were acquired at a trigger delay of 50% end systole. In vivo data were acquired in
six healthy volunteers (1 male, age 24±2, weight 59±5kg, heart rate 70±10beats/min,
max/min 55/90beats/min). Written informed consent according to institutional
guidelines was obtained prior to imaging.
The myocardium was manually segmented
according to the AHA model with three transmural layers
13 and helix and
transverse angles were calculated
14. Segment-wise comparison was performed
by correlation and Bland-Altman analysis. Correlation coefficients, mean signed
differences, mean absolute differences and root-mean-squared-errors (RMSE) are
reported. Mean diffusivity (MD), fractional anisotropy (FA), transmural helix
angle slope and range as well as mean and standard deviation of the transverse
angle were computed. To model the effect of reduced SNR due to prolonged TE a
subset of signal averages from data acquired with 74.5mT/m was analyzed.
Results
Figure 2 shows helix angle
maps acquired with different Gmax as well as a segment-wise
comparison in one volunteer. The corresponding transverse angle analysis is
shown in Figure 3. Imaging at 30mT/m failed in two volunteers resulting in non-circumferential
alignment of the diffusion tensors’ principal eigenvector (up to RMSE of 20.5° for
helix and transverse angulation). The segment-wise comparison for different Gmax
at apex, mid and base across all volunteers is presented in Figure 4. Across all
slices a correlation coefficient (R2) of 0.89±0.06, 0.87±0.04 and
0.77±0.11 for 60mT/m, 40mT/m and 30mT/m was found relative to data acquired at Gmax=74.5mT/m.
The corresponding RMSEs were 10.3±2.4°, 11.0±1.8°, 15.0±3.7° for helix angles and
8.1±2.2°, 9.0±2.0°, 11.7±3.8° for transverse angles. The (bias) signed mean
difference was -3.0±2.0°, -1.9±2.9°, -4.6±4.0° for helix angles and 0.5±2.3°, -0.5±2.8°,
-1.2±3.4° for transverse angles across all slices. The RMSE was lowest at mid
ventricular level. The SNR analysis resulted in an RMSE of 3.9±2.8°/4.9±2.8°/7.0±4.6°
and 2.6±1.4°/3.6±1.7°/4.9±2.0° for helix and transverse angles for Gmax
30mT/m, 40mT/m, 60mT/m. The slice wise analysis of
transmural helix angle variation, transverse angulation, MD and FA is shown in Table
1.
Discussion
In this work, two confounding
factors relating to the maximum available gradient amplitude for spin-echo cDTI
were studied. SNR simulations showed that for helix angle estimation 43% of the
RMSE and for transverse angle estimation 39% of the RMSE are attributed to the
lower SNR with increased TE. This indicates that residual motion, registration
and segmentation induced errors are present. To further minimize the impact of
cardiac motion during long encoding times the trigger delay may be optimized for
individual subjects
15. Furthermore, spatial resolution may be
increased reducing intra voxel dephasing at the cost of SNR. In general, G
max of
30mT/m appeared to be insufficient for robust spin-echo cardiac DTI.
Conclusion
Second-order motion compensated
diffusion gradients allow for spin-echo cardiac DTI during free breathing on
clinical MR systems with standard gradient performance of 40 mT/m.
Acknowledgements
This work is supported by UK EPSRC
(EP/I018700/1).References
1. Edelman R, Gaa J, Wedeen VJ, et
al. In vivo measurement of water diffusion
in the human heart. Magn Reson Med 1994;32:423–428.
2. Nielles-Vallespin
S, Mekkaoui C, Gatehouse P, et al. In vivo diffusion tensor MRI of the human
heart: Reproducibility of breath-hold and navigator-based approaches. Magn
Reson Med 2013;70:454–465.
3. Stoeck CT,
Kalinowska A, von Deuster C, et al. Dual-phase cardiac diffusion tensor imaging
with strain correction. PLoS One 2014;9: e107159.
4.
Gamper U, Boesiger P, Kozerke S. Diffusion imaging of the in vivo heart using
spin echoes--considerations on bulk motion sensitivity. Magn Reson Med 2007;75:331–337.
5. Sosnovik DE, Mekkaoui C, Huang
S et al. Microstructural impact of ischemia and
bone marrow-derived cell therapy revealed with diffusion tensor magnetic
resonance imaging tractography of the heart in vivo. Circulation
2014;129:1731-1741
6. Moulin K, Croisille P, Feiweier T et al. In vivo free-breathing DTI and IVIM of the whole human heart using a
real-time slice-followed SE-EPI navigator-based sequence: A reproducibility
study in healthy volunteers. Magn Reson Med 2015. 10.1002/mrm.25852.
7.Welsh
C, Di Bella E, Hsu E. Higher-order motion-compensation for in vivo cardiac diffusion
tensor imaging in rats. IEEE Trans Med Imaging 2015;34:1843–1853.
8. Stoeck CT,
von Deuster C, Genet M, et al. Second order motion compensated spin-echo
diffusion tensor imaging of the human heart. Magn Reson Med 2015. doi: 10.1002/
mrm.25784.
9.
Nguyen C, Fan Z, Sharif, B et al. In vivo three-dimensional high resolution
cardiac diffusion-weighted MRI: A motion compensated diffusion-prepared
balanced steady-state free precession approach. Magn Reson Med 2013; doi 10.1002/mrm.25038
10. von
Deuster C, Stoeck
CT, Genet
M, et al. Spin echo
versus stimulated echo diffusion tensor imaging of the in vivo human heart. Magn Reson Med. 2015;doi:
10.1002/mrm.25998.
11.
Scott A, Ferreira P, Nielles-Vallespin S et al. Optimal diffusion weighting for
in vivo cardiac diffusion tensor imaging Magn Reson Med 2015. doi: 10.1002/mrm.25418.
12. Wilm
BJ, Svensson J, Henning A et al. Reduced field-of-view MRI using outer volume
suppression for spinal cord diffusion imaging. Magn Reson Med 2007;57:625–630.
13. McGill LA, Ismail TF, Nielles-Vallespin S et al. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic
resonance in hypertrophic cardiomyopathy. JCMR
2012;14:86
14. Scollan
DF, Holmes A, Winslow R et al. Histological validation of myocardial
microstructure obtained from diffusion tensor magnetic resonance imaging. Am J
Physiol 1998;275:H2308–H2318.
15.
Stoeck CT, Toussaint N, Boesiger P et al. Sequence timing optimization in
multi-slice diffusion tensor imaging of the beating heart. Proc. ISMRM 2010.